John Henry Elder

Q: What Schools Are Affiliated With John Henry Elder

John Henry Elder is affiliated with the following schools: Texas A&M University, Virginia Tech

John Henry Elder's AcademicInfluence.com Rankings

John Henry Elder

Biology

#12841

World Rank

#16344

Historical Rank

Biochemistry

#2219

World Rank

#2365

Historical Rank

biology Degrees

Download Badge

Biology

John Henry Elder's Degrees

PhD Biochemistry University of California, Berkeley
Bachelors Chemistry Stanford University

Why Is John Henry Elder Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John Henry Elder's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose (1984) (1657)
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. (1998) (672)
Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. (1977) (566)
endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. (1982) (487)
Inhibitors of HIV-1 protease by using in situ click chemistry. (2006) (447)
Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations. (1984) (440)
Nucleotide sequence and genomic organization of feline immunodeficiency virus. (1989) (400)
Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. (1977) (333)
Comparison of two host cell range variants of feline immunodeficiency virus (1990) (253)
von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. (1986) (249)
1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors (2005) (240)
Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice (1980) (228)
Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family (1977) (224)
A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. (2008) (213)
Minimum Requirements for Efficient Transduction of Dividing and Nondividing Cells by Feline Immunodeficiency Virus Vectors (1999) (201)
Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses (2000) (190)
Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. (2006) (186)
The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. (1983) (167)
Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. (1984) (162)
Distinct subsets of retroviruses encode dUTPase (1992) (159)
Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. (2007) (137)
Neurological abnormalities associated with feline immunodeficiency virus infection. (1994) (133)
Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes (1991) (128)
Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease Inhibitors (2003) (126)
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus (1992) (125)
Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. (2004) (114)
Nucleotide Sequence of the Envelope Gene of Gardner-Arnstein Feline Leukemia Virus B Reveals Unique Sequence Homologies with a Murine Mink Cell Focus-Forming Virus (1983) (112)
Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. (1995) (112)
Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. (1992) (107)
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. (2010) (104)
Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus (1993) (97)
Binding of Recombinant Feline Immunodeficiency Virus Surface Glycoprotein to Feline Cells: Role of CXCR4, Cell-Surface Heparans, and an Unidentified Non-CXCR4 Receptor (2001) (93)
Conformational flexibility in the flap domains of ligand-free HIV protease. (2007) (91)
Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells Is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120-DC-SIGN Binding (2002) (88)
Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides. (1978) (88)
A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs* (2005) (83)
Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. (2000) (82)
Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures (1995) (81)
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. (1984) (77)
Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. (1996) (76)
Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. (1978) (75)
Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. (1998) (75)
Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding (1997) (70)
Demonstration that orf2 Encodes the Feline Immunodeficiency Virus Transactivating (Tat) Protein and Characterization of a Unique Gene Product with Partial Rev Activity (1999) (70)
Feline immunodeficiency virus is a lentivirus associated with an AIDS‐like disease in cats (1989) (68)
Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. (1994) (66)
Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). (1993) (65)
Crystal structure of dUTP pyrophosphatase from feline immunodeficiency virus (1996) (65)
The role of retroviral dUTPases in replication and virulence. (2001) (62)
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus (2005) (62)
Workshop Summary: Lessons from the Cat: Feline Immunodeficiency Virus as a Tool to Develop Intervention Strategies against Human Immunodeficiency Virus Type 1 (1998) (62)
Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZB X NZW mice (1981) (59)
Influence of ORF2 on host cell tropism of feline immunodeficiency virus. (1996) (56)
Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants (1999) (54)
Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor. (1997) (54)
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. (1978) (53)
Characterization of a Highly Pathogenic Molecular Clone of Feline Immunodeficiency Virus Clade C (2004) (53)
A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors. (2002) (52)
Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies (1987) (52)
Molecular mechanisms of FIV infection. (2008) (51)
Expanded Host Cell Tropism and Cytopathic Properties of Feline Immunodeficiency Virus Strain PPR Subsequent to Passage through Interleukin-2-Independent T Cells (2000) (51)
Differential expression of two distinct xenotropic viruses in NZB mice. (1980) (48)
Synthesis in vitro of intrinsic membrane proteins by free, membrane-bound, and Golgi apparatus-associated polyribosomes from rat liver. (1976) (48)
Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. (1994) (48)
Endoglycosidases from Flavobacterium meningosepticum application to biological problems. (1989) (47)
Factors That Increase the Effective Concentration of CXCR4 Dictate Feline Immunodeficiency Virus Tropism and Kinetics of Replication (2004) (47)
Sequential CD134-CXCR4 Interactions in Feline Immunodeficiency Virus (FIV): Soluble CD134 Activates FIV Env for CXCR4-Dependent Entry and Reveals a Cryptic Neutralization Epitope (2006) (46)
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. (1998) (44)
Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. (1995) (43)
Human Immunodeficiency Virus Type 1 and Influenza Virus Exit via Different Membrane Microdomains (2007) (43)
Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis (1992) (42)
Specific Interaction of Feline Immunodeficiency Virus Surface Glycoprotein with Human DC-SIGN (2004) (41)
Defining HIV-1 protease substrate selectivity. (2002) (40)
Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. (1994) (40)
Antibody directed to determinants of a Moloney virus derived MCF GP70 recognizes a thymic differentiation antigen (1983) (39)
Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators (2002) (39)
FIV infection of IL-2-dependent and -independent feline lymphocyte lines: Host cells range distinctions and specific cytokine upregulation (1998) (38)
Molecular properties of feline immunodeficiency virus (FIV). (1993) (38)
Structures of feline immunodeficiency virus dUTP pyrophosphatase and its nucleotide complexes in three crystal forms. (2000) (37)
Crystallographic Fragment‐Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease (2014) (36)
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120 (2006) (36)
Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. (1995) (36)
Neurotoxic effects of feline immunodeficiency virus, FIV-PPR. (1998) (36)
Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3 (2007) (36)
Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. (1981) (35)
Structural studies of FIV and HIV‐1 proteases complexed with an efficient inhibitor of FIV protease (2000) (34)
Small molecule regulation of protein conformation by binding in the Flap of HIV protease. (2013) (33)
Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. III. Role of input virus and MCF recombinants in disease. (1983) (33)
Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats (1994) (32)
Immunoregulatory properties of human esophageal tumor extract. (1979) (32)
Feline Immunodeficiency Virus Vif Localizes to the Nucleus (2000) (32)
Viral Evolution in Response to the Broad-Based Retroviral Protease Inhibitor TL-3 (2001) (31)
Molecular dissection of Rauscher virus gp70 by using monoclonal antibodies: localization of acquired sequences of related envelope gene recombinants. (1980) (31)
Molecular Basis for the Relative Substrate Specificity of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Proteases (2001) (31)
HIV- and FIV-Derived gp120 Alter Spatial Memory, LTP, and Sleep in Rats (2000) (31)
Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease (2000) (31)
Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis. (1996) (30)
Carbohydrate side chains of Rauscher leukemia virus envelope glycoproteins are not required to elicit a neutralizing antibody response (1986) (28)
Characterization of a membrane surface glycoprotein associated with T-cell activation. (1985) (28)
Structural analysis of the major envelope glycoprotein (gp70) of the amphotropic and ecotropic type C viruses of wild mice. (1978) (27)
Replication Properties of Clade A/C Chimeric Feline Immunodeficiency Viruses and Evaluation of Infection Kinetics in the Domestic Cat (2008) (26)
A simple and rapid procedure for the purification of plasmid DNA using reverse-phase C18 silica beads. (1983) (25)
Protection against feline leukemia virus infection by use of an inactivated virus vaccine. (1991) (25)
Is resistance futile? (2003) (24)
Derivatives of 4‐amino‐3,6‐disulfonato‐1, 8‐naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells (1993) (24)
Type 1 diabetes pathogenesis is modulated by spontaneous autoimmune responses to endogenous retrovirus antigens in NOD mice (2017) (24)
Identification of the protein product of the c-mos proto-oncogene in mouse testes. (1988) (23)
Characterization of endogenous and recombinant proviral elements of a highly tumorigenic AKR cell line (1991) (23)
Multigene family of endogenous retroviruses: recombinant origin of diversity. (1978) (22)
Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. (2006) (22)
Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases (2003) (22)
Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases (1997) (22)
Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells. (1981) (22)
Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. (2010) (21)
Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups. (1979) (21)
Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3 (2004) (21)
Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. (2008) (21)
Mapping of the CXCR4 Binding Site within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein (2008) (21)
Natural feline leukemia virus variant escapes neutralization by a monoclonal antibody via an amino acid change outside the antibody-binding epitope (1987) (21)
B-MuX: a unique murine C-type virus containing the "env" gene of xenotropic viruses and the "gag" gene of the ecotropic virus. (1978) (20)
Accessory Genes Confer a High Replication Rate to Virulent Feline Immunodeficiency Virus (2013) (20)
Fine Definition of the CXCR4-Binding Region on the V3 Loop of Feline Immunodeficiency Virus Surface Glycoprotein (2010) (20)
Cortical neuronal cytoskeletal changes associated with FIV infection. (1997) (20)
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3 (2004) (20)
Altered Gag Polyprotein Cleavage Specificity of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Mutant Proteases as Demonstrated in a Cell-Based Expression System (2006) (20)
Nearest-neighbor interactions of the major RNA tumor virus glycoprotein on murine cell surfaces. (1978) (20)
Association of elevated serum glycoprotein gp70 with increased gp70 immune complex formation and accelerated lupus nephritis in autoimmune male BXSB mice. (1984) (19)
Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. (2011) (19)
OrfA Downregulates Feline Immunodeficiency Virus Primary Receptor CD134 on the Host Cell Surface and Is Important in Viral Infection (2010) (19)
Applications of the FIV Model to Study HIV Pathogenesis (2018) (19)
Structural analysis of Rauscher virus Gp70 using monoclonal antibodies: sites of antigenicity and P15(E) linkage. (1982) (18)
Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134 (2009) (18)
Chemical determination of the m1 Moloney sarcoma virus pP60gag gene order: evidence for unique peptides in the carboxy terminus of the polyprotein. (1978) (18)
In vitro construction of a B-tropic virus by recombination: B-tropism is a cryptic phenotype of xenotropic murine retroviruses. (1980) (18)
Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes. (1982) (17)
Dissecting the molecular anatomy of the nervous system: Analysis of RNA and protein expression in whole body sections of laboratory animals (1986) (17)
Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases. (2003) (16)
Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase (2001) (16)
Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. (1995) (15)
Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro. (1980) (14)
Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats (2006) (14)
Influence of Soils on Bacterial Contamination of a Watershed from Septic Sources 1 (1975) (14)
Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine. (2001) (14)
Identification of Amino Acid Residues Important for Heparan Sulfate Proteoglycan Interaction within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein (2011) (14)
HIV‐derived protein gp120 suppresses P3 potential in rats: potential implications in HIV‐associated dementia (2000) (13)
COMPARATIVE STUDIES ON THE SMALL BACILLUS BACTERIOPHAGES (1986) (13)
Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens. (1981) (13)
Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats (1999) (13)
A continuous fluorometric assay for the feline immunodeficiency virus protease. (1997) (12)
Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates. (2006) (12)
Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue. (2001) (11)
Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats. (1995) (11)
Pathogenicity and Rapid Growth Kinetics of Feline Immunodeficiency Virus Are Linked to 3′ Elements (2011) (11)
Analysis of the S 3 and S 3 * subsite specificities of feline immunodeficiency virus ( FIV ) protease : Development of a broad-based protease inhibitor efficacious against FIV , SIV , and HIV in vitro and ex vivo (1998) (11)
Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. (2013) (11)
A microanalytical protein assay using laser densitometry. (1984) (11)
Isolation of two novel envelope recombinant leukemogenic viruses from moloney leukemia virus stocks (1981) (10)
HIV induces synaptic hyperexcitation via cGMP-dependent protein kinase II activation in the FIV infection model (2018) (10)
Engineering Properties of Soils as Related to Mineralogy and Particle-Size Distribution1 (1984) (9)
FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge (2018) (9)
Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease. (2011) (9)
Prolonged waking reduces human immunodeficiency virus glycoprotein 120- or tumor necrosis factor alpha-induced apoptosis in the cerebral cortex of rats (2004) (7)
Generation of Infectious Feline Immunodeficiency Virus (FIV) Encoding FIV/Human Immunodeficiency Virus Chimeric Protease (2010) (7)
Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase. (2018) (7)
On the Role of Recombinant Retroviruses in Murine Leukemia (1984) (7)
Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection (2011) (7)
A single-stranded nucleic acid binding sequence common to the heterogeneous nuclear ribonucleoparticle protein A1 and murine recombinant virus gp70. (1990) (6)
An unusual retrovirus-like sequence identified in human DNA. (1990) (6)
Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection. (2012) (6)
Selective Interaction of Heparin with the Variable Region 3 within Surface Glycoprotein of Laboratory-Adapted Feline Immunodeficiency Virus (2014) (6)
Structural diversity among retroviral gene products: a molecular approach to the study of biological function through structural variability. (1981) (5)
of the Feline Immunodeficiency Virus Surface Glycoprotein 2 3 (2008) (5)
Calcium uptake by sarcoplasmic reticulum of rat muscle: inhibition by DDT. (1979) (5)
Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis. (1995) (5)
Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi’s Sarcoma-Associated Herpesvirus (2016) (5)
Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence (2019) (5)
Toxicity of 2,4-D and Picloram to Fresh Water Algae (1970) (4)
The Toxicity of 2,4-D and Picloram Herbicides to Fish (1970) (4)
Scale Calcification in a Chrysophycean Alga: A Test System for the Effects of DDT on Biological Calcification (1971) (4)
[Cat retroviruses and human retroviruses: elements of comparison]. (1989) (2)
A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL (2019) (2)
Modification of immuno blotting technique for detection and quantitation of infectious virus in cell mono layers (1984) (2)
Soil Survey of Maury County, Tennessee (1959) (2)
endoP . fN-Acetylglucosaminidase F : Endoglycosidase from ' Flavobacterium meningosepticum-that cleaves both high-mannose and complex ' glycoproteins ( Rauscher leukemia virus gp 70 / glycan structure / deglycosylation / N-linked glycan ) (1)
Unidentified Non-CXCR 4 Receptor CXCR 4 , Cell-Surface Heparans , and an Glycoprotein to Feline Cells : Role of Immunodeficiency Virus Surface Binding of Recombinant Feline (2001) (1)
Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort (2016) (1)
Expanded Host Cell Tropism and Cytopathic Properties of Feline Immunodeficiency Virus Strain PPR Subsequent to Passage through Interleukin2Independent Interleukin2Independent Interleukin2Independent 2Independent 2Independent T Cells (2000) (1)
Crystal structure of FIV dUTP pyrophosphatase (1996) (1)
Inhibition by DDT of Calcium Accumulation in Isolated Cell Fractions from Rat Muscle (1973) (1)
Professional field day: A stimulus to undergraduate programs in plant science curricula (1974) (1)
mAbs as Probes of Protein Structure: Molecular Diversity among the Envelope Glycoproteins (Gp70S) of the Murine Retroviruses (2019) (1)
Correction (2022) (0)
The structure of FIV 12S protease in complex with TL-3 (2007) (0)
Structure of HIV Protease NL4-3 in an Unliganded State (2007) (0)
STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR (1998) (0)
Fv-1 locus of the mouse. Abstr. (1978) (0)
Design, Synthesis, and Biological Evaluation of HIV/FIV Protease Inhibitors (I) Incorporating a Conformationally Constrained Macrocycle with a Small P3′ Residue. (2001) (0)
FIV DUTP PYROPHOSPHATASE (1997) (0)
Mapping of the CXCR4 Binding Site within Variable Region 3 of the Feline Immunodeﬁciency Virus Surface Glycoprotein (cid:1) (2008) (0)
Identification of Amino Acid Residues Important for Heparan Sulfate 1 Proteoglycan (HSPG) Interaction within Variable Region 3 of the Feline 2 (2011) (0)
Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120 (2007) (0)
Structure of the D30N active site mutant of FIV proteinase complexed with a statine-based inhibitor (1997) (0)
Toxicity of 2,4-D and picloram to fresh and salt water algae. (1970) (0)
Lessons from the cat: use of feline immunodeficiency virus (FIV) as a means to develop intervention strategies effective against human immunodeficiency virus type 1 (HIV-1) (1998) (0)
HIV-1 Protease NL4-3 in complex with inhibitor, TL-3 (2006) (0)
Comparison ofTwoHostCellRangeVariants ofFeline Immunodeficiency Virus (1990) (0)
HIV-1 Protease NL4-3 1X mutant (2006) (0)
HIV-1 Protease NL4-3 6X mutant (2006) (0)
interference with receptor binding. via inhibition of virus release rather than infection by a monoclonal antibody to CD9 is Blocking of feline immunodeficiency virus (2013) (0)
HIV Protease with inhibitor AB-2 (2005) (0)
Cover Picture: 1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors (ChemBioChem 7/2005) (2005) (0)
HIV-1 Protease NL4-3 3X mutant in complex with inhibitor, TL-3 (2006) (0)
Crystal Structure of 6s-98S FIV Protease with Darunavir bound (2011) (0)
FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge (2018) (0)
Evaluation ofFeline Immunodeficiency VirusandFelineLeukemia VirusTransmembrane Peptides forSerological Diagnosis (1992) (0)
Proteolytic activity of feline immunodeficiency virus protease prepared by total chemical synthesis (1995) (0)
Inhibition of nzb anti-h-2d cell mediated lympholysis (cml) by anti-gp70 antibody. Abstr. (1980) (0)
1 Applications of the FIV Model to Study HIV 2 Pathogenesis 3 (2018) (0)
Selection of Drug-Resistant Feline Immunodeficiency Virus (FIV) Encoding FIV/HIV Chimeric Protease in the Presence of HIV-Specific Protease Inhibitors (2013) (0)
Structure of HIV protease 6X mutant in complex with AB-2. (2007) (0)
Selected soils of Madison County, Virginia: their chemical properties (1974) (0)
Correction (1979) (0)
HIV Protease with Scripps AB-3 Inhibitor (2005) (0)
[Comparative characteristics of the peptide maps of the major proteins of influenza viruses type A]. (1979) (0)
HIV protease inhibitors with small P3 residues. Broad-based Protease Inhibitors Efficacious Against FIV, SIV (1999) (0)
SYNTHESIS OF INTRINSIC PROTEINS OF RAT LIVER ENDOMEMBRANES. (1975) (0)
Apo Wild-type HIV Protease in the open conformation (2007) (0)
Chemical and physical properties of soils in Northumberland and Lancaster counties, Virginia (1961) (0)
Structure of HIV protease 6X mutant in apo form (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John Henry Elder?

John Henry Elder is affiliated with the following schools: